Han Qiao

Guangzhou Municipal And Guangdong Provincial Key Laboratory Of Protein Modification And Degradation
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

RNF138 promotes cisplatin resistance and PD-L1-mediated immune evasion via JAK2/STAT3 activation in nasopharyngeal carcinoma.

RNF138 promotes cisplatin resistance and PD-L1-mediated immune evasion via JAK2/STAT3 activation in nasopharyngeal carcinoma.

Journal: Cell reports

Published: December 17, 2025

LncRNA DYNLRB2-AS1 promotes gemcitabine resistance of nasopharyngeal carcinoma by inhibiting the ubiquitination degradation of DHX9 protein.

LncRNA DYNLRB2-AS1 promotes gemcitabine resistance of nasopharyngeal carcinoma by inhibiting the ubiquitination degradation of DHX9 protein.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: March 21, 2024

Systemic longitudinal immune profiling identifies proliferating Treg cells as predictors of immunotherapy benefit: biomarker analysis from the phase 3 CONTINUUM and DIPPER trials.

Systemic longitudinal immune profiling identifies proliferating Treg cells as predictors of immunotherapy benefit: biomarker analysis from the phase 3 CONTINUUM and DIPPER trials.

Journal: Signal transduction and targeted therapy

Published: March 19, 2024

Ac4C modification of lncRNA SIMALR promotes nasopharyngeal carcinoma progression through activating eEF1A2 to facilitate ITGB4/ITGA6 translation.

Ac4C modification of lncRNA SIMALR promotes nasopharyngeal carcinoma progression through activating eEF1A2 to facilitate ITGB4/ITGA6 translation.

Journal: Oncogene

Published: March 18, 2024

The circadian gene ARNTL2 promotes nasopharyngeal carcinoma invasiveness and metastasis through suppressing AMOTL2-LATS-YAP pathway.

The circadian gene ARNTL2 promotes nasopharyngeal carcinoma invasiveness and metastasis through suppressing AMOTL2-LATS-YAP pathway.

Journal: Cell death & disease

Published: December 19, 2023

Tissue-resident microbiota signature in nasopharyngeal carcinoma.

Tissue-resident microbiota signature in nasopharyngeal carcinoma.

Journal: Microbiome

Published: November 28, 2023

PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma.

PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma.

Journal: Nature communications

Published: September 27, 2023

Broadening oncological boundaries: the intratumoral microbiota.

Broadening oncological boundaries: the intratumoral microbiota.

Journal: Trends in microbiology

Published: September 20, 2023

UV-induced photodegradation of emerging para-phenylenediamine quinones in aqueous environment: Kinetics, products identification and toxicity assessments.

UV-induced photodegradation of emerging para-phenylenediamine quinones in aqueous environment: Kinetics, products identification and toxicity assessments.

Journal: Journal of hazardous materials

Published: September 11, 2023

Emerging clinical relevance of microbiome in cancer: promising biomarkers and therapeutic targets.

Emerging clinical relevance of microbiome in cancer: promising biomarkers and therapeutic targets.

Journal: Protein & cell

Published: August 31, 2023

Transcription factor ATMIN facilitates chemoresistance in nasopharyngeal carcinoma.

Transcription factor ATMIN facilitates chemoresistance in nasopharyngeal carcinoma.

Journal: Cell death & disease

Published: July 26, 2023

Phosphorylation-mediated interaction between human E26 transcription factor 1 and specific protein 1 is required for tumor cell migration.

Phosphorylation-mediated interaction between human E26 transcription factor 1 and specific protein 1 is required for tumor cell migration.

Journal: Acta biochimica et biophysica Sinica

Published: October 28, 2022

Showing 1-12 of 31

Last Updated: 09/26/2026